alpha-aminopyridine has been researched along with Lambert-Eaton Myasthenic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortese, F; De Giglio, L; Pennisi, EM | 1 |
| Lundh, H; Nilsson, O; Rosén, I | 1 |
1 review(s) available for alpha-aminopyridine and Lambert-Eaton Myasthenic Syndrome
| Article | Year |
|---|---|
Current therapy of the Lambert-Eaton myasthenic syndrome.
Topics: Aminopyridines; Guanidine; Guanidines; Humans; Immunosuppressive Agents; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Parasympathomimetics; Plasma Exchange | 1990 |
1 other study(ies) available for alpha-aminopyridine and Lambert-Eaton Myasthenic Syndrome
| Article | Year |
|---|---|
Aminopiridines in the treatment of multiple sclerosis and other neurological disorders.
Topics: 4-Aminopyridine; Aminopyridines; Humans; Lambert-Eaton Myasthenic Syndrome; Multiple Sclerosis; Nervous System Diseases; Potassium Channel Blockers; Quality of Life | 2020 |